Literature DB >> 12366325

Illumination and reading performance in age-related macular degeneration.

Alex R Bowers1, Carolyn Meek, Nicola Stewart.   

Abstract

BACKGROUND: Previous studies have compared low vision reading performance at optimal task illuminance and consulting room illuminance (500 to 600 lux). However, it is uncertain the extent to which low vision reading performance can be improved when task illumination is increased from levels more representative of those found in the typical living room (50 lux) to levels likely to maximise performance.
METHODS: Reading performance of 20 subjects with age-related macular degeneration (AMD) was assessed for a range of print sizes using sentence reading charts at six levels of task illuminance (50 to 5,000 lux). Subjects read without low vision devices.
RESULTS: Sentence reading acuity and critical print size improved by a factor of two over the 50 to 5,000 lux range, while maximum reading rate improved by a factor of 1.4. For the majority of subjects (70 per cent), the optimal task illuminance (determined objectively) was higher (median 3,500 lux) than the subjectively preferred task illuminance (median 2,450 lux). Reading performance was significantly better at the optimal illuminance than at illuminances equivalent to those found in the domestic environment (50 lux) or consulting room (600 lux).
CONCLUSIONS: The majority of AMD patients will require task illumination of at least 2,000 lux to maximise reading performance. Optimal illumination should be determined individually for each patient using both objective measures of performance, such as reading acuity, and subjective assessments of visual comfort.

Entities:  

Year:  2001        PMID: 12366325     DOI: 10.1111/j.1444-0938.2001.tb04957.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  15 in total

1.  Home lighting assessment for clients with low vision.

Authors:  Monica S Perlmutter; Anjali Bhorade; Mae Gordon; Holly Hollingsworth; Jack E Engsberg; M Carolyn Baum
Journal:  Am J Occup Ther       Date:  2013 Nov-Dec

2.  Effects of Lighting on Reading Speed as a Function of Letter Size.

Authors:  William Seiple; Olga Overbury; Bruce Rosenthal; Tiffany Arango; J Vernon Odom; Alan R Morse
Journal:  Am J Occup Ther       Date:  2018 Mar/Apr

3.  Reading ability and reading engagement in older adults with glaucoma.

Authors:  Angeline M Nguyen; Suzanne W van Landingham; Robert W Massof; Gary S Rubin; Pradeep Y Ramulu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-22       Impact factor: 4.799

4.  Differences in vision between clinic and home and the effect of lighting in older adults with and without glaucoma.

Authors:  Anjali M Bhorade; Monica S Perlmutter; Brad Wilson; Jamie Kambarian; Sidney Chang; Melike Pekmezci; Mae Gordon
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

5.  Reading Digital with Low Vision.

Authors:  Gordon E Legge
Journal:  Visible Lang       Date:  2016-08

6.  Effect of Different Illumination Sources on Reading and Visual Performance.

Authors:  Male Shiva Ram; Rishi Bhardwaj
Journal:  J Ophthalmic Vis Res       Date:  2018 Jan-Mar

Review 7.  Low vision rehabilitation: An update.

Authors:  Mark E Wilkinson; Khadija S Shahid
Journal:  Saudi J Ophthalmol       Date:  2017-10-27

8.  Test-retest Variability of a Standardized Low Vision Lighting Assessment.

Authors:  Walter Wittich; Lorie St Amour; Jonathan Jarry; William Seiple
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

Review 9.  How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review.

Authors:  Jamie Enoch; Lee Jones; Deanna J Taylor; Carol Bronze; James F Kirwan; Pete R Jones; David P Crabb
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

10.  Enhanced text spacing improves reading performance in individuals with macular disease.

Authors:  Sally Blackmore-Wright; Mark A Georgeson; Stephen J Anderson
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.